Skip to main content

About your Search

20130101
20130131
SHOW
STATION
CNBC 2
WBAL (NBC) 1
LANGUAGE
Search Results 0 to 2 of about 3 (some duplicates have been removed)
CNBC
Jan 9, 2013 6:00pm EST
back in june. let's check in with dr. ron cohen the founder and ceo of acorda therapeutics. welcome back to "mad money." >> thanks very much, jim. >> i was going back to our interview in july of last year, and so much has changed. at the time you were only talking about pre-clinical or rat studies of what your drug could be for stroke. since then, i was looking at your presentation this morning -- this week. 66 people with stroke, at least six months trying this. give me the progression. there have got to be people initially happy with the study. >> well, it's still a blinded study, jim. that means we have no idea who's done well on placebo versus drug, but we're going to find out pretty soon. we're getting the results of that trial in the second quarter of this year. we're very excited to see those results. >> i think people want to understand, it's not just everybody who has had a stroke. it's particular kind of people who face a stroke problem, right? >> yeah, well, about half the people who have had a stroke wind up with permanent disabilities. as a result, reduced mobility, red
Search Results 0 to 2 of about 3 (some duplicates have been removed)